Elevated toll-like receptor 3 inhibits pancreatic β-cell proliferation through G1 phase cell cycle arrest

Area of Science:

• Immunology
• Endocrinology
• Cell Biology

Background:

• Innate and acquired immune systems are implicated in chronic inflammatory diseases like obesity and type 2 diabetes.
• Immune system activation also influences cell proliferation and survival.
• Pancreatic beta-cell mass is crucial for metabolic regulation.

Purpose of the Study:

• To investigate the role of Toll-like receptor 3 (TLR3) in nutrient sensing and its effect on pancreatic beta-cell mass.
• To elucidate the signaling pathways involved in TLR3-mediated beta-cell loss.

Main Methods:

• Utilized pancreatic beta-cell lines.
• Stimulated TLR3 with polyinosinic-polycytidylic acid (poly(I:C)).
• Assessed protein levels of cyclin D1/2, employed proteasome inhibitor MG132, and used gene silencing of TRIF.
• Analyzed p38 kinase activity and cell cycle regulation.

Main Results:

• TLR3 activation by poly(I:C) led to decreased cyclin D1/2 protein levels in beta-cells.
• This decline was reversible with the proteasome inhibitor MG132, suggesting ubiquitin-proteasome degradation.
• p38 kinase activity was implicated in this degradation and associated with G1 cell cycle arrest.
• Gene silencing of TRIF inhibited p38 activity, confirming its role in TLR3-mediated effects.

Conclusions:

• TLR3 can sense nutrient signals and induce pancreatic beta-cell mass loss via G1 cell cycle arrest.
• The TRIF/p38 signaling pathway is involved in this process, likely through the ubiquitin/proteasome-dependent degradation of cyclin D.
• These findings suggest a role for TLR3 in beta-cell dysfunction during metabolic surplus, potentially contributing to diabetes pathogenesis.